12/22/2025
Alzheimer’s disease costs in the U.S. could reach $1 trillion by 2050. Advances in disease-modifying therapies and diagnostics could change that — but only if they reach patients in time. https://buff.ly/GRiCEPA
Eli Lilly and Company sponsored content on POLITICO.
DMs to POLITICO are unmonitored. To reach Lilly directly, please message .